Accès à distance ? S'identifier sur le proxy UCLouvain
Implications of the ACCORD Lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i)
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche – Journal Article, Research Support, Non-U.S. Gov't |
---|---|
Publication date | 2010 |
Language | Anglais |
Journal information | "Current Medical Research and Opinion" - Vol. 26, no. 8, p. 1793-1797 (2010) |
Peer reviewed | yes |
Publisher | Informa Healthcare ((United Kingdom) London) |
issn | 0300-7995 |
e-issn | 1473-4877 |
Publication status | Publié |
Affiliations |
UCL
- Cliniques universitaires Saint-Luc UCL - SSS/IREC - Institut de recherche expérimentale et clinique UCL - (SLuc) Service d'endocrinologie et de nutrition |
MESH Subject | Risk Reduction Behavior ; Risk Factors ; Lipids - blood ; Humans ; Dyslipidemias - blood - epidemiology ; Diabetes Mellitus, Type 2 - blood - epidemiology ; Atherosclerosis - blood - epidemiology |
Keywords | ACCORD trial ; Dyslipidaemia ; High-density lipoprotein cholesterol ; Residual cardiovascular risk ; Triglycerides ; Type 2 diabetes |
Links |
Bibliographic reference | Fruchart, Jean Charles ; Hermans, Michel ; Sacks, Frank M.. Implications of the ACCORD Lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i). In: Current Medical Research and Opinion, Vol. 26, no. 8, p. 1793-1797 (2010) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/33608 |